Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(53 sites)
United States
City of Hope, Duarte, California UC IRVINE Health, Orange, California UC Davis Comprehensive Cancer Center, Sacramento, California Stanford Cancer Institute, Stanford, California University of Colorado Cancer Center, Aurora, Colorado Florida Cancer Specialists, Sarasota, Florida Moffitt Cancer Center and Research Institute, Tampa, Florida Dana Farber Cancer Institute, Boston, Massachusetts Henry Ford Cancer, Detroit, Michigan START Midwest, Grand Rapids, Michigan Columbia University, New York, New York NYU Langone Health, New York, New York Memorial Sloan Kettering Cancer Center, New York, New York University of Oklahoma, Oklahoma City, Oklahoma Sarah Cannon Research Institue, Nashville, Tennessee Mary Crowley Cancer Research, Dallas, Texas MD Anderson, Houston, Texas NEXT Dallas, Irving, Texas NEXT Oncology San Antonio, San Antonio, Texas START Texas, San Antonio, Texas NEXT Oncology Virginia, Fairfax, Virginia France
West Cancer Institute, Angers Institut Bergonie, Bordeaux Hospital Louise Pradel, Bron Oscar Lambret Center of Lillle, Lille Cancer Institute of Montpellier, Montpellier Institute of Cancer of Strasbourg, Strasbourg Germany
Universitäts Klinikum Köln, Cologne Klinikum Esslingen GmbH, Esslingen am Neckar Krankenhaus Bethanien Moers, Moers Klinkum Nurnberg Paracelsus Medical Unviersity, Nuremberg Italy
Department of Medical Oncology - Azienda Ospedaliero Uniersitaria delle Marche, Ancona Centro Di Riferimento Oncologico, Aviano Institute Romagnolo per lo Studio Tumori, Meldola Niguarda Cancer Center, Milan Istituto Nazionale Tumori IRCCS Fondazione "G. Pascale", Naples San Luigi Hospital, Orbassano AUSL Romagna - S.M. delle Croci Hospital, Ravenna Netherlands
Netherlands Cancer Institute Antoni van Leeuwenhoek, Amsterdam Puerto Rico
Pan American Center for Oncology Trials, San Juan Spain
START Barcelona - Hospital HM Nou Delfos, Barcelona Institut Catala d'Oncologia Hospital, Barcelona University Clinic of Navarra, Madrid Fundacion MD Anderson Cancer Center, Madrid Hospital Universitario 12 de Octubre, Madrid NEXT Oncology - Quirónsalud Madrid University Hospital, Madrid University Clinic of Navarra, Pamplona Hospital Universitario Virgen Macarena, Seville La Fe University and Polytechnic Hospital, Valencia Hospital Universitario Miguel Servet, Zaragoza